- Drugs
- Wednesday, 18 Dec 2019
Medical Marijuana, Inc. Appoints New Chief Financial Officer
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has promoted its VP of Corporate Finance Brooke Beers to Chief Financial Officer of the Company.
"Brooke's contributions to the Company have been extraordinary," said Medical Marijuana, Inc. COO Blake Schroeder. "He's helped us overcome several financial obstacles that many cannabis companies face every day and he has helped us significantly improve our public reporting practices to increase transparency."
Beers was hired by Medical Marijuana, Inc. in 2017 and has since been leading the Company's accounting department, handling the Company's budget management, public financial reports, e-commerce offerings, and forecasting needs.
"Working with the Medical Marijuana, Inc. team has been an incredibly rewarding experience," said Beers. "Last December, the Brightfield Group reported that our Company represents 10 percent of the entire CBD market and I'm proud to be a part of that financial milestone and many more to come. It's encouraging to work with a large group of highly motivated professionals and claim our stake in the global CBD industry."
Related Industry Updates
Synthetic Menthol Market Overview | COVID-19 Pandemic Impact, Competitive Landscape, Size, Value Demand, Regional Analysis and Forecast to 2027
May 06, 2021
Glenmark Becomes the First Pharmaceutical Company in India to Receive Regulatory Approval for Oral Antiviral Favipiravir, for the Treatment of Mild to Moderate COVID-19
Jun 20, 2020
Sterilization Technologies Market is expected to reach US$ 9,109.08 million by 2030
Feb 16, 2024
Johnson & Johnson Announces Collaboration with U.S. Department of Health & Human Services to Accelerate Development of a Potential Novel Coronavirus Vaccine
Feb 13, 2020
US Pharmaceutical Market is expected to reach US$ 1,285.79 billion by 2030
Jan 12, 2024
North America In-Office Teeth Whitening Products Market is expected to reach US$ 5,818.23 million by 2028
Apr 21, 2023
Asia Pacific Transdermal Drug Delivery System Market Prospects & Upcoming Trends and Opportunities Upto 2027
Sep 05, 2020